Skip to main content
. 2017 Feb 15;2(2):563–572. doi: 10.1021/acsomega.6b00181

Figure 2.

Figure 2

(a) High-content detection of hepatocellular CSCs in the cadmium-treated HepG2 cell culture. CSC markers CD133, CD44, and ALDH1 were concurrently monitored using the QD-conjugated antibodies. (b) Line graph represents the quantitative determination of hepatocellular CSCs obtained from the HepG2 cell culture in response to the incremental concentrations of cadmium. (c) Semiquantitative RT-PCR analysis of CD133, CD44, and ALDH1 expression in HepG2 cells treated with and without cadmium (1 μM) over the period of 72 h. The values are means ± SD from three independent experiments.